乳腺包裹性乳头状癌的临床和病理特征分析
Analysis of clinicopathological characteristics of breast encapsulated papillarycarcinoma
Received date: 2018-05-30
Online published: 2019-02-25
王顺利, 邓双双, 高慧, 肖天羽, 高金莉 . 乳腺包裹性乳头状癌的临床和病理特征分析[J]. 诊断学理论与实践, 2019 , 18(1) : 89 -92 . DOI: 10.16150/j.1671-2870.2019.01.018
Objective: To analyze the clinical-pathological features, treatment and prognosis of encapsulated papillary carcinoma (EPC) of breast. Methods: Thirty-one cases with EPC were enrolled. Clinical symptoms and pathological characteristics were retrospectively analyzed. The immunohistochemical staining included P63, CK5/6, Calponin, ER, PR, HER2, Ki67. Results: All of the cases were woman with a mean age of 63 years old, ranging from 34 to 83 years old. Palpable mass and nipple discharge were the most common symptoms. The mass ranged in size from 0.8-6.5 cm (mean 3 cm). Microscopic examination showed that majority of the EPCs were single lesion. A thick fibrous capsule is evident under low-power examination. The nodule surrounded by capsule was composed of delicate fibrovascular stalks, covered with a monomorphic population of neoplastic epithelial cells with low-or intermediate-grade nuclei. The epithelial cells were typically arranged in either solid or cribriform pattern. The tumor cells were positive for ER and PR, but were HER2 negative; P63, CK5/6 and Calponin were negative. The positive percentage for Ki67 was under 10%. Conclusions: EPC is a breast tumor with good prognosis generally found in elderly women. The tumor cells are typically arranged in either solid or cribriform pattern and diffusely positive for ER and PR, but HER2 was negative. Myoepithelial cell markers including P63, CK5/6 and Calponin were negative. The positive percentage for Ki67 is under 10%. The EPC is diagnosed according to these characteristics, which are helpful for the designing of reasonable treatment.
Key words: Breast; Encapsulated papillary carcinoma; Immunohistochemistry
[1] | Steponaviěienè L, Gudaviěienè D, Briedienè R, et al. Dia-gnosis, treatment, and outcomes of encapsulated papillary carcinoma: a single institution experience[J]. Acta Med Litu, 2018, 25(2):66-75. |
[2] | Li X, Xu Y, Ye H, et al. Encapsulated papillary carcinoma of the breast: A clinicopathological study of 49 cases[J]. Curr Probl Cancer, 2018, 42(3):291-301. |
[3] | Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone[J]. Cancer, 1983, 52(1):14-19. |
[4] | Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas[J]. Am J Clin Pathol, 2005, 123(1):36-44. |
[5] | Collins LC, Carlo VP, Hwang H, et al. Intracystic papillary carcinomas of the breast: a reevaluation using a pa-nel of myoepithelial cell markers[J]. Am J Surg Pathol, 2006, 30(8):1002-1007. |
[6] | Tariq N, Mamoon N, Usman M, et al. Encapsulated papil-lary carcinoma (EPC) of breast: A clinical, pathological and immunohistochemical analysis of eight cases[J]. J Pak Med Assoc, 2016, 66(11):1490-1493. |
[7] | Lam WW, Tang AP, Tse G, et al. Radiology-Pathology conference: papillary carcinoma of the breast[J]. Clin Imaging, 2005, 29(6):396-400. |
[8] | Rageth CJ, O′Flynn EA, Comstock C, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)[J]. Breast Cancer Res Treat, 2016, 159(2):203-213. |
[9] | Rakha EA, Tun M, Junainah E, et al. Encapsulated pa-pillary carcinoma of the breast: a study of invasion associated markers[J]. J Clin Pathol, 2012, 65(8):710-714. |
[10] | Wynveen CA, Nehhozina T, Akram M, et al. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up[J]. Am J Surg Pathol, 2011, 35(1):1-14. |
[11] | Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its varia-nts: a clinicopathological study of 77 cases[J]. Hum Pathol, 1994, 25(8):802-809. |
[12] | Mulligan AM, O′Malley FP. Papillary lesions of the breast: a review[J]. Adv Anat Pathol, 2007, 14(2):108-119. |
[13] | Solorzano CC, Middleton LP, Hunt KK, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast[J]. Am J Surg, 2002, 184(4):364-368. |
[14] | MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases[J]. Virchows Arch, 2003, 443(5):609-617. |
[15] | Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues[J]. Histopatho-logy, 2008, 52(1):20-29. |
/
〈 |
|
〉 |